Payment overview · 2025
General Payments
$96.25
1 reported records · 1 companies
Healthcare provider profile · identity verified
Lawrence H. Lee, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · SAINT PAUL, MN · NPI 1053384784
Verified facts
What the public records show
CMS Open Payments records show Lawrence H. Lee, M.D. received $96.25 in general payments during 2025 across 1 reported records.
Abbott Laboratories accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Abbott Laboratories | Unresolved — no canonical attribution shown | $96.25 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $96.25 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| TACTICATH ABLATION CATHETER, SENSOR ENABLED Normalized: tacticath ablation catheter sensor enabled |
Device | Abbott Laboratories | $96.25 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1090 | 318 |
| Losartan Potassium | Losartan Potassium | 642 | 191 |
| Lisinopril | Lisinopril | 624 | 181 |
| Levothyroxine Sodium | Levothyroxine Sodium | 529 | 151 |
| Amlodipine Besylate | Amlodipine Besylate | 464 | 149 |
| Omeprazole | Omeprazole | 414 | 131 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 414 | 118 |
| Metoprolol Succinate | Metoprolol Succinate | 405 | 111 |
| Hydrochlorothiazide | Hydrochlorothiazide | 336 | 98 |
| Metformin Hcl | Metformin Hcl | 294 | 88 |
| Gabapentin | Gabapentin | 291 | 90 |
| Simvastatin | Simvastatin | 281 | 81 |
| Tamsulosin Hcl | Tamsulosin Hcl | 240 | 67 |
| Finasteride | Finasteride | 211 | 61 |
| Furosemide | Furosemide | 211 | 74 |
| Pantoprazole Sodium | Pantoprazole Sodium | 161 | 46 |
| Allopurinol | Allopurinol | 160 | 47 |
| Metformin Hcl Er | Metformin Hcl | 160 | 48 |
| Zolpidem Tartrate | Zolpidem Tartrate | 155 | 39 |
| Trazodone Hcl | Trazodone Hcl | 148 | 44 |
| Pravastatin Sodium | Pravastatin Sodium | 139 | 39 |
| Potassium Chloride | Potassium Chloride | 138 | 40 |
| Eliquis | Apixaban | 136 | 41 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 131 | 54 |
| Clopidogrel | Clopidogrel Bisulfate | 128 | 30 |
| Citalopram Hbr | Citalopram Hydrobromide | 118 | 34 |
| Lorazepam | Lorazepam | 111 | 32 |
| Escitalopram Oxalate | Escitalopram Oxalate | 108 | 35 |
| Atenolol | Atenolol | 107 | 30 |
| Famotidine | Famotidine | 105 | 32 |
| Sertraline Hcl | Sertraline Hcl | 99 | 24 |
| Trulicity | Dulaglutide | 97 | 14 |
| Carvedilol | Carvedilol | 96 | 32 |
| Warfarin Sodium | Warfarin Sodium | 94 | 30 |
| Alendronate Sodium | Alendronate Sodium | 91 | 30 |
| Alprazolam | Alprazolam | 86 | 30 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 86 | 27 |
| Metoprolol Tartrate | Metoprolol Tartrate | 85 | 32 |
| Prednisone | Prednisone | 84 | 42 |
| Doxazosin Mesylate | Doxazosin Mesylate | 81 | 22 |
| Duloxetine Hcl | Duloxetine Hcl | 80 | 25 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 79 | 19 |
| Mirtazapine | Mirtazapine | 79 | 16 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 79 | 25 |
| Jardiance | Empagliflozin | 76 | 20 |
| Ventolin Hfa | Albuterol Sulfate | 72 | 28 |
| Spironolactone | Spironolactone | 71 | 22 |
| Ozempic | Semaglutide | 69 | 20 |
| Azithromycin | Azithromycin | 66 | 59 |
| Celecoxib | Celecoxib | 59 | 17 |
| Donepezil Hcl | Donepezil Hcl | 59 | 13 |
| Tizanidine Hcl | Tizanidine Hcl | 59 | 14 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 58 | 15 |
| Fluticasone Propionate | Fluticasone Propionate | 57 | 22 |
| Amoxicillin | Amoxicillin | 55 | 38 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 54 | 17 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 54 | 33 |
| Cephalexin | Cephalexin | 53 | 35 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 53 | 15 |
| Xarelto | Rivaroxaban | 53 | 14 |
| Chlorthalidone | Chlorthalidone | 52 | 15 |
| Doxycycline Hyclate | Doxycycline Hyclate | 49 | 40 |
| Synthroid | Levothyroxine Sodium | 48 | 14 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 47 | 17 |
| Ezetimibe | Ezetimibe | 47 | 12 |
| Tramadol Hcl | Tramadol Hcl | 47 | 18 |
| Clonazepam | Clonazepam | 46 | suppressed |
| Klor-Con M20 | Potassium Chloride | 46 | 18 |
| Oxycodone Hcl | Oxycodone Hcl | 41 | suppressed |
| Glipizide | Glipizide | 40 | 12 |
| Glipizide Er | Glipizide | 40 | 16 |
| Paroxetine Hcl | Paroxetine Hcl | 40 | 13 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 39 | suppressed |
| Pregabalin | Pregabalin | 39 | 12 |
| Montelukast Sodium | Montelukast Sodium | 38 | 12 |
| Naproxen | Naproxen | 37 | 14 |
| Paxlovid | Nirmatrelvir/Ritonavir | 36 | 35 |
| Sodium Chloride | 0.9 % Sodium Chloride | 36 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 34 | 30 |
| Nitroglycerin | Nitroglycerin | 33 | 25 |
| Quetiapine Fumarate | Quetiapine Fumarate | 33 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 31 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 30 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 30 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 29 | 14 |
| Irbesartan | Irbesartan | 29 | suppressed |
| Meloxicam | Meloxicam | 29 | suppressed |
| Torsemide | Torsemide | 29 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 29 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 27 | suppressed |
| Baclofen | Baclofen | 26 | suppressed |
| Bumetanide | Bumetanide | 26 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 26 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 26 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 25 | suppressed |
| Sucralfate | Sucralfate | 25 | suppressed |
| Bupropion Xl | Bupropion Hcl | 24 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 24 | 20 |
| Sotalol | Sotalol Hcl | 24 | suppressed |
| Methocarbamol | Methocarbamol | 23 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 23 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 23 | suppressed |
| Estradiol | Estradiol | 22 | 11 |
| Glimepiride | Glimepiride | 22 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 21 | 17 |
| Acyclovir | Acyclovir | 20 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 20 | suppressed |
| Nystatin | Nystatin | 20 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 19 | suppressed |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 19 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 18 | suppressed |
| Mounjaro | Tirzepatide | 18 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 18 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 18 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 17 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 17 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 17 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 17 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 17 | suppressed |
| Valsartan | Valsartan | 17 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 16 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 16 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 16 | suppressed |
| Januvia | Sitagliptin Phosphate | 16 | suppressed |
| Aripiprazole | Aripiprazole | 15 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 15 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Ibuprofen | Ibuprofen | 15 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 15 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 15 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 15 | suppressed |
| Repatha Sureclick | Evolocumab | 15 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 14 | suppressed |
| Fenofibrate | Fenofibrate | 14 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 14 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 14 | suppressed |
| Lovastatin | Lovastatin | 14 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 13 | suppressed |
| Creon | Lipase/Protease/Amylase | 13 | suppressed |
| Hydrocortisone | Hydrocortisone | 13 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 13 | suppressed |
| Novolog Flexpen | Insulin Aspart | 13 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 13 | suppressed |
| Temazepam | Temazepam | 13 | suppressed |
| Verapamil Er | Verapamil Hcl | 13 | suppressed |
| Diazepam | Diazepam | 12 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 12 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 12 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 12 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 11 | suppressed |
| Fluconazole | Fluconazole | 11 | suppressed |
| Indapamide | Indapamide | 11 | suppressed |
| Sulindac | Sulindac | 11 | suppressed |
| Telmisartan | Telmisartan | 11 | suppressed |
| Testosterone | Testosterone | 11 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $96.25 · 1 records | Abbott Laboratories | TACTICATH ABLATION CATHETER, SENSOR ENABLED | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error